期刊文献+

骨桥蛋白基因剪切体在胃癌组织中的表达及意义 被引量:11

Expression of osteopontin splice variant and its clinical significance in gastric cancer
原文传递
导出
摘要 目的:研究胃癌组织中骨桥蛋白( OPN)基因剪切体OPN-A、OPN-B和OPN-C mRNA的表达,及其在胃癌发展和转移过程中的作用。方法采用实时荧光定量PCR法检测66例胃癌组织和癌旁正常组织中OPN-A mRNA、OPN-B mRNA和OPN-C mRNA的表达差异,分析OPN-A mRNA、OPN-B mRNA和OPN-C mRNA的表达与胃癌患者临床病理特征及预后的关系。结果 OPN-A mRNA和OPN-B mRNA在胃癌组织中的表达量分别为癌旁正常组织的1.06和1.27倍,差异无统计学意义(均P>0.05);而OPN-C mRNA在胃癌组织中的表达量为癌旁正常组织的3.21倍,差异有统计学意义(P=0.001)。 OPN-A mRNA和OPN-B mRNA在胃癌组织中的表达与胃癌的浸润深度、肿瘤直径、有无远处转移、淋巴结转移情况以及分化程度均无关(均P>0.05);而OPN-C mRNA的表达与肿瘤的浸润深度、肿瘤直径、有无远处转移、淋巴结转移情况有关(均P<0.05),仅与肿瘤的分化程度无关(P>0.05)。 OPN-C mRNA高表达组患者的中位生存时间为14个月,明显低于低表达组患者(29个月, P=0.03)。结论 OPN-C可能促进胃癌的发展和转移,而OPN-A和OPN-B的表达与胃癌的发展和转移无明显关系。 OPN-C mRNA表达水平可作为评估胃癌患者预后的分子指标。 Objective To investigate the expression of osteopontin ( OPN) splice variant mRNA, including the three isoforms OPN-A, OPN-B, and OPN-C, to explore its correlation with clinicopathologic features in gastric cancer, and to elucidate their role in tumor invasion and distant metastasis of gastric cancer. Methods The expression of OPN-A, OPN-B and OPN-C mRNA were detected by real-time reverse transcriptase-polymerase chain reaction in 66 gastric cancer tissues. The relationship between the expression of OPN-A, OPN-B and OPN-C mRNA and clinicopathologic features of gastric cancer was analyzed. Results The expression of OPN-C mRNA in the gastric cancer tissue was 3. 21-fold higher than that in peritumoral mucosal tissue, showing a significant difference between them (P〈0.001). OPN-C mRNA expression was correlated with the depth of tumor invasion, tumor diameter, lymph node meatastasis, distant meatastasis and had no correlation with differentiation grades. The low expression of OPN-C mRNA was correlated with long survival benefit ( P=0.03) . The expression of OPN-A and OPN-B mRNA had no significant relationship with clinicopathologic features of gastric cancer. Conclusions One of the isoform of osteopontin ( OPN) OPN-C mRNA is overexpressed in gastric cancer. The overexpression of OPN-C mRNA may reflect the progression and is associated with the prognosis of gastric cancer. OPN-C mRNA may have value as a prognostic biomarker in gastric cancer. However, the expression of OPN-A and OPN-B are not correlated with the progression and metastasis of gastric cancer.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2015年第6期427-430,共4页 Chinese Journal of Oncology
基金 山东省科技发展计划项目(2009GG20002101)
关键词 胃肿瘤 骨桥蛋白 基因表达 预后 Stomach neoplasms Osteopontin Gene expression Prognosis
  • 相关文献

参考文献15

  • 1孙现军,左文述,马恒,侯文红,蔡淑萍,姜希宏.骨桥蛋白mRNA在胃癌中的表达及其临床意义[J].中华肿瘤杂志,2005,27(5):292-295. 被引量:19
  • 2Mirza M, Shaughnessy E, Hurley JK, et al. Osteopontin-e is a selective marker of breast cancer[ J]. lnt ] Cancer, 2008, 122 (4) :889-897.
  • 3Deng 3, Liang H, Wang D, et al. Investigation of the reemxence patterns of gastric cancer fnllowing a curative resection [ J]. Surg Today, 2011,41(2) :210-215.
  • 4Hallegger M, Llorian M, Smith CW. Alternative splicing: global insights[J]. FEBS J, 2010, 277(4):856-866.
  • 5Chen M, Manley JL. Mechanisms of alternative splicing regulatian: insights from molecular and genomics approaches[ J]. Nat Rev Mol Cell Biol, 2009, 10( 11 ) :741-754.
  • 6Blencowe BJ. Alternative splicing: new insights from gldN analyses [ J ]. Cell, 2006,126( 1 ) :37-47.
  • 7Pajares MJ, Ezponda T, Catena R, et al. Alternative splicing: an emerging topic in molecular and clinical oneology [ J ]. Lancet Oncol, 2007, 8(4):349-357.
  • 8Gimba ER, Tilli TM. Human osteopontin splicing isoforms: known roles, potential clinical applications and activated signaling pathways[J]. Cancer Lett, 2013, 331(1) :11-17.
  • 9Zhang MX,Xu YJ,Zhu MC,et al. Overexpressed ostepontin-c as a potential biomarker for esophageal squamous cell careinoma[ J ]. Asian Pac J Cancer Prey, 2013, 14(12) :7315-7319.
  • 10Tilli TM, Franco VF, Robbs BK, et al. Osteopontin-e splicing isotbrm contributes to ovarian cancer progression [J]. Mol Cancer Res, 2011, 9(3) :280-293.

二级参考文献17

  • 1Oates A J, Barraelough R, Rudland PS. The role of osteopontin in tumorigenesis and metastasis. Invasion Metastasis, 1997,17:1-15.
  • 2Rudland PS, Higgins AP, Tanani ME, et al. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res, 2002,62 : 3417-3427.
  • 3Craig AM, Bowden GT, Chambers AF, et al. Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts. Int J Cancer, 1990,46:133-137.
  • 4Behrend El, Craig AM, Wilson SM, et al. Reduced malignancy of ras-transformed NIH3T3 cells expressing antisense osteopontin RNA. Cancer Res, 1994,54 : 832-837.
  • 5Chomczynski P, Sacchi N. Single-Step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem,1987, 162:156-159.
  • 6Bayless KJ, Davis GE. Identification of dual alpha 4betal integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin. J Biol Chem, 2001,276: 13483-13489.
  • 7McDevitt TC, Nelson KE, Stayton PS. Constrained cell recognition peptides engineered into streptavidin. Biotechnol Prog, 1999, 15:391-396.
  • 8Yokosaki Y, Matsuura N,Sasaki T,et al. The integrin alpha(9)beta(1) binds to a novel recognition sequece(SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J Biol Chem, 1999,274:36328-36334.
  • 9Tuck AB, O' Malley FP, Singhal H, et al. Osteopontin expression in a group of lymph node negative breast cancer patients, Int J Cancer,1998,79 : 502-508.
  • 10Teruyoshi UE, Yokozaki H, Kitadai Y, et al. Co-Expression of osteopontin and CD44v9 in gastric cancer. Int J Cancer, 1998,79:127-132.

共引文献18

同被引文献102

引证文献11

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部